𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Meta-analysis: recurrence and survival following the use of sirolimus in liver transplantation for hepatocellular carcinoma

✍ Scribed by Menon, K. V.; Hakeem, A. R.; Heaton, N. D.

Book ID
119826748
Publisher
John Wiley and Sons
Year
2012
Tongue
English
Weight
201 KB
Volume
37
Category
Article
ISSN
0269-2813

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Sirolimus-based immunosuppression in liv
Sirolimus-based immunosuppression in liver transplantation for hepatocellular carcinoma: A meta-analysis
✍ Wenhua Liang; Dongping Wang; Xiaoting Ling; Andrew Allen Kao; Yuan Kong; Yushu S πŸ“‚ Article πŸ“… 2011 πŸ› John Wiley and Sons 🌐 English βš– 786 KB

Sirolimus (SRL) is a novel immunosuppressant with antitumor properties. We performed a meta-analysis to determine whether SRL can improve patient survival and decrease the risks of tumor recurrence in patients with a pretransplant diagnosis of hepatocellular carcinoma (HCC). We searched databases fo

Impact of sirolimus on the recurrence of
Impact of sirolimus on the recurrence of hepatocellular carcinoma after liver transplantation
✍ Srinath Chinnakotla; Gary L. Davis; Sugam Vasani; Peter Kim; Koji Tomiyama; Edmu πŸ“‚ Article πŸ“… 2009 πŸ› John Wiley and Sons 🌐 English βš– 147 KB πŸ‘ 1 views

Tumor recurrence after liver transplantation for hepatocellular carcinoma is associated with a poor prognosis. Because immunosuppression is a well-known risk factor for tumor growth, it is surprising that its possible role in the outcome of liver transplantation has been poorly evaluated. We perform

Tumor recurrence following liver transpl
Tumor recurrence following liver transplantation for hepatocellular carcinoma: Role of tumor proliferation status
✍ Aileen E. Marshall; Simon M. Rushbrook; Sarah L. Vowler; Christopher R. Palmer; πŸ“‚ Article πŸ“… 2010 πŸ› John Wiley and Sons 🌐 English βš– 297 KB

The selection of patients with hepatocellular carcinoma for liver transplantation is currently based on the size and number of tumors to minimize the risk of recurrence. These criteria measure tumor bulk but may not reflect tumor behavior accurately. A biological marker of tumor behavior could aid w

Impact of pretransplantation transarteri
Impact of pretransplantation transarterial chemoembolization on survival and recurrence after liver transplantation for hepatocellular carcinoma
✍ Thomas Decaens; FranΓ§oise Roudot-Thoraval; Solange Bresson-Hadni; Carole Meyer; πŸ“‚ Article πŸ“… 2005 πŸ› John Wiley and Sons 🌐 English βš– 115 KB

The actual impact of transarterial chemoembolization before liver transplantation (LT) for hepatocellular carcinoma (HCC) on patient survival and HCC recurrence is not known. Between 1985 and 1998, 479 patients with HCC in 14 French centers were evaluated for LT. Among these 479 patients, this case-